1-14 of 14
Elizabeth Repasky
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 31: Favorable impact of higher environmental temperature on clinical outcomes in breast cancer - Does residence matter? A NCDB and SEER population-based study

Ashish Gupta, Kristopher Attwood, Kush Gupta, Asha Gandhi, Stephen Edge, Kazuaki Takabe, Elizabeth Repasky, Shipra Gandhi
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 31.
https://doi.org/10.1158/1538-7445.AM2022-31
Published: 15 June 2022
View article titled, Abstract 31: Favorable impact of higher environmental temperature on clinical outcomes in breast cancer - Does residence matter? A NCDB and SEER population-based study
Journal Articles

Abstract 4057: Measurement of myeloid derived suppressor cells (MDSC), T regulatory cells (Treg), CD8+ and CD4+T-cells, and cytokines/chemokines in patients with metastatic melanoma treated with pembrolizumab and propranolol

Shipra Gandhi, Manu Pandey, Kristopher M. Attwood, Cheryl Allen, Joseph Tario, Shin La Shu, Maria Levis, Suzanne M. Stack, Paul Wallace, Paul Bogner, Igor Puzanov, Mark J. Bucsek, Elizabeth Repasky, Marc S. Ernstoff
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 4057.
https://doi.org/10.1158/1538-7445.AM2019-4057
Published: 01 July 2019
View article titled, Abstract 4057: Measurement of myeloid derived suppressor cells (MDSC), T regulatory cells (Treg), CD8<sup>+</sup> and CD4<sup>+</sup>T-cells, and cytokines/chemokines in patients with metastatic melanoma treated with pembrolizumab and propranolol
Journal Articles

Abstract 2069: Activity of an EphA2-targeted docetaxel nanoliposome in pancreatic patient-derived models as monotherapy and in combination with gemcitabine

Daryl C. Drummond, Ninfa L. Straubinger, Tista Roy Chaudhuri, Michael Moser, Walid S. Kamoun, Lia Luus, Zhaohua Richard Huang, Suresh Tipparaju, Bryan Gillard, Carl Morrison, Elizabeth Repasky, Dmitri B. Kirpotin, Robert M. Straubinger
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 2069.
https://doi.org/10.1158/1538-7445.AM2016-2069
Published: 15 July 2016
View article titled, Abstract 2069: Activity of an EphA2-targeted docetaxel nanoliposome in pancreatic patient-derived models as monotherapy and in combination with gemcitabine
Journal Articles

Abstract 1214: Effects of dovitinib on fibroblast growth factor receptor-2 (FGFR2) expressing pancreatic cancer

Hao Zhang, Bonnie Hylander, Charles LeVea, Elizabeth Repasky, Robert Straubinger, Alex Adjei, Wen Wee Ma
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 1214.
https://doi.org/10.1158/1538-7445.AM2012-1214
Published: 15 April 2012
View article titled, Abstract 1214: Effects of dovitinib on fibroblast growth factor receptor-2 (FGFR2) expressing pancreatic cancer
Journal Articles

Abstract 1939: TL32711, a novel Smac mimetic, exerts significant antitumor efficacy in primary pancreatic adenocarcinoma model

Wen Wee Ma, Hao Zhang, Bonnie Hylander, Charles LeVea, Elizabeth Repasky, David Weng, Jennifer Burns, Srinivas Chunduru, Martin Graham, Gerald Fetterly, Mark McKinlay, Alex Adjei
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 1939.
https://doi.org/10.1158/1538-7445.AM2012-1939
Published: 15 April 2012
View article titled, Abstract 1939: TL32711, a novel Smac mimetic, exerts significant antitumor efficacy in primary pancreatic adenocarcinoma model
Journal Articles

Abstract 1610: Predicting NSCLC outcomes based on tumor growth in SCID mice

Mark W. Hennon, Bonnie Hylander, Carl Morrison, Austin Miller, Adrienne Groman, Elisabeth Dexter, Sai Yendamuri, Todd L. Demmy, Alex Adjei, Mary Reid, Elizabeth Repasky, Chukwumere Nwogu
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): 1610.
https://doi.org/10.1158/1538-7445.AM2011-1610
Published: 15 April 2011
View article titled, Abstract 1610: Predicting NSCLC outcomes based on tumor growth in SCID mice
Journal Articles

Abstract 906: Body temperature and thermal discomfort among breast cancer survivors

Chi-Chen Hong, Kathleen Kokolus, Christine Ambrosone, Stephen Edge, Swati Kulkarni, Elizabeth Repasky
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 906.
https://doi.org/10.1158/1538-7445.AM10-906
Published: 15 April 2010
View article titled, Abstract 906: Body temperature and thermal discomfort among breast cancer survivors
Journal Articles

Abstract #3692: Inhibition of MAPK signaling enhances Sorafenib-mediated cytoxicity in human cancer cells in vitro and in vivo

Chunrong Yu, Haikuo Tang, Bret Friday, Jeffrey Miner, Mark Chapman, Elizabeth Repasky, Alex Adjei
Journal: Cancer Research
Cancer Res (2009) 69 (9_Supplement): 3692.
Published: 01 May 2009
View article titled, Abstract #3692: Inhibition of MAPK signaling enhances Sorafenib-mediated cytoxicity in human cancer cells <em>in vitro</em> and <em>in vivo</em>
Journal Articles

Fever-range whole body hyperthermia increases the efficacy of radiation therapy by selectively increasing the percentage of perfused tumor blood vessels

Maegan Capitano, John Schueckler, Wainwright Jaggernauth, Arindam Sen, Elizabeth Repasky
Journal: Cancer Research
Cancer Res (2008) 68 (9_Supplement): 5767.
Published: 01 May 2008
View article titled, Fever-range whole body hyperthermia increases the efficacy of radiation therapy by selectively increasing the percentage of perfused tumor blood vessels
Journal Articles

Potent anticarcinoma activity of the anti-CD70 antibody h1F6 conjugated to the tubulin inhibitor auristatin via an uncleavable linker

Ezogelin Oflazoglu, Ivan Stone, Jamie Miyamoto, Kristine Gordon, Leia Smith, Kim Kissler, Christopher Wood, Elizabeth Repasky, Iqbal Grewal, Che-Leung Law, Hans-Peter Gerber
Journal: Cancer Research
Cancer Res (2008) 68 (9_Supplement): 4064.
Published: 01 May 2008
View article titled, Potent anticarcinoma activity of the anti-CD70 antibody h1F6 conjugated to the tubulin inhibitor auristatin via an uncleavable linker
Journal Articles

Erlotinib exhibits enhanced capacity to modulate growth and survival pathways in epithelial primary pancreatic xenografts derived from Whipple resection

Elizabeth Buck, Bonnie Hylander, Alexandra Eyzaguirre, John Gibbs, Jeffrey Senfeld, Regina Sennello, David Young, Katherine Richardson, David Epstein, John Haley, Mark Miglarese, Elizabeth Repasky, Kenneth Iwata
Journal: Cancer Research
Cancer Res (2008) 68 (9_Supplement): 1941.
Published: 01 May 2008
View article titled, Erlotinib exhibits enhanced capacity to modulate growth and survival pathways in epithelial primary pancreatic xenografts derived from Whipple resection
Journal Articles

Characterization of the resistance mechanisms of HL60 leukemia cell derivatives to Apo2L/TRAIL

Jinrong Cheng, Bonnie Hylander, Maria Baer, Xin Chen, Elizabeth Repasky
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 1265.
Published: 01 May 2005
View article titled, Characterization of the resistance mechanisms of HL60 leukemia cell derivatives to Apo2L/TRAIL
Journal Articles

Targeted Immunotherapy Using Reconstituted Chaperone Complexes of Heat Shock Protein 110 and Melanoma-associated Antigen gp100

Xiang-Yang Wang, Xing Chen, Masoud H. Manjili, Elizabeth Repasky, Robert Henderson, John R. Subjeck
Journal: Cancer Research
Cancer Res (2003) 63 (10): 2553–2560.
Published: 15 May 2003
View article titled, Targeted Immunotherapy Using Reconstituted Chaperone Complexes of Heat Shock Protein 110 and Melanoma-associated Antigen gp100
Open the PDF for Targeted Immunotherapy Using Reconstituted Chaperone Complexes of Heat Shock Protein 110 and Melanoma-associated Antigen gp100 in another window
Journal Articles

Development of a Recombinant HSP110-HER-2/ neu Vaccine Using the Chaperoning Properties of HSP110

Masoud H. Manjili, Robert Henderson, Xiang-Yang Wang, Xing Chen, Ying Li, Elizabeth Repasky, Latif Kazim, John R. Subjeck
Journal: Cancer Research
Cancer Res (2002) 62 (6): 1737–1742.
Published: 15 March 2002
View article titled, Development of a Recombinant HSP110-HER-2/ <em>neu</em> Vaccine Using the Chaperoning Properties of HSP110
Open the PDF for Development of a Recombinant HSP110-HER-2/ <em>neu</em> Vaccine Using the Chaperoning Properties of HSP110 in another window